Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 152 pseudogene (RNU7-152P) is a human genomic sequence on chromosome 6, classified as a pseudogene related to the functional U7 small nuclear RNA. Unlike the original U7 snRNA, which plays a key role in histone mRNA maturation, RNU7-152P lacks functional activity and does not encode active RNA or protein. Pseudogenes result from duplication or retrotransposition events and typically accumulate mutations rendering them nonfunctional[10][6][4][3][5]. There is no evidence for a biological, pathological, or pharmacological role for RNU7-152P in human health, disease, or therapy. Key points: - Not a drug target, receptor, or functional molecule. - No associated biological function, disease relevance, or druggability. - Entry is correct as a gene record, but not correct as a therapeutic target or molecule of pharmaceutical interest. - Most information on functional U7 snRNA relates to histone RNA processing, not to the RNU7-152P pseudogene[1][11]. Summary: RNU7-152P is a non-functional pseudogene and should not be considered a therapeutic target, receptor, or molecule of direct biological or disease significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 152 pseudogene (RNU7-152P).